Entering text into the input field will update the search result below

Danaher, Thermo Fisher Scientific & Abbott Laboratories Are The Top Players Of Immunoassay Market

Sep. 20, 2021 1:57 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Market growth influenced due to following factors-

  • Increasing incidence of chronic and infectious diseases.
  • Technological advancements in immunoassay instruments and introduction of novel automated systems.
  • Growth in the biotechnology and biopharmaceutical industries.

Global market size-

According to the new market research report Immunoassay Market is expected to reach $39.0 billion by 2026, at a CAGR of 6.6% during the forecast period.

Leading Players-

The global immunoassay market is consolidated. The prominent players operating in this market include Danaher (US), Thermo Fisher Scientific (US), Abbott Laboratories (US) and Roche (Switzerland).

Danaher (US) is one of the leading players in the immunoassay market. With a wide distribution network across the globe and a strong product portfolio, it has established itself as one of the leading market players. The company has a strong presence in the North America, Western Europe and Asia Pacific.

Thermo Fisher Scientific (US) is one of the leading players in the immunoassay market. The leading position can be attributed to its strong brand recognition and extensive product portfolio in this market. The company holds a strong foothold in the North America, Europe and Asia Pacific.

Abbott Laboratories (US) held the third position in the immunoassay market in 2020. The company holds the leading position with its strong geographical presence in the US and is also escalating its business operations in the emerging markets.

For More Details, Download PDF Brochure

Geographic Overview -

Based on region, the immunoassay market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.Latin America and the Middle East & Africa. In 2020. The large share of this regional segment is attributed to the increasing incidence of chronic diseases and improved healthcare infrastructure.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.